Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures

BACKGROUND: Insulin-like growth factor 1 receptor (IGF1R) targeted therapies have resulted in responses in a small number of patients with advanced metastatic Ewing's sarcoma. We performed morphoproteomic profiling to better understand response/resistance mechanisms of Ewing's sarcoma to I...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbiah, Vivek, Naing, Aung, Brown, Robert E., Chen, Helen, Doyle, Laurence, LoRusso, Patricia, Benjamin, Robert, Anderson, Pete, Kurzrock, Razelle
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071831/
https://www.ncbi.nlm.nih.gov/pubmed/21494688
http://dx.doi.org/10.1371/journal.pone.0018424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071831/
https://www.ncbi.nlm.nih.gov/pubmed/21494688
http://dx.doi.org/10.1371/journal.pone.0018424

Ejemplares similares